Press release
Soft Tissue Sarcoma Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight
Soft Tissue Sarcoma Pipeline
(Albany, United States) As per DelveInsight's assessment, globally, Soft Tissue Sarcoma pipeline constitutes 125+ key companies continuously working towards developing 130+ Soft Tissue Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Soft Tissue Sarcoma Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Soft Tissue Sarcoma Market.
The Soft Tissue Sarcoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Request for Sample Report here @ Soft Tissue Sarcoma Pipeline Analysis [https://www.delveinsight.com/report-store/soft-tissue-sarcoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Some of the key takeaways from the Soft Tissue Sarcoma Pipeline Report:
* Soft Tissue Sarcoma Companies across the globe are diligently working toward developing novel Soft Tissue Sarcoma treatment therapies with a considerable amount of success over the years.
* Soft Tissue Sarcoma companies working in the treatment market are Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Apexigen, Lytix Biopharma, Incyte Corporation, Iovance Biotherapeutics, Aadi Bioscience, Inc., AVEO Pharmaceuticals, Bayer, VasGene Therapeutics, Mirati Therapeutics, Novartis Pharmaceuticals, Incyte Corporation, Tracon Pharmaceuticals, Jiangsu Hengrui Medicine, Exelixis, Qbiotics, AstraZeneca, Loxo Oncology, ImmunityBio, Monopar Therapeutics, Chipscreen Biosciences, Ltd., Agenus, C4 Therapeutics, Inc., Noxopharm Limited, Moleculin Biotech, Inc., Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Tracon Pharmaceuticals Inc., Guangdong Xiangxue Precision Medical Technology Co., Ltd., Cornerstone Pharmaceuticals, Takara Bio Inc., Jazz Pharmaceuticals, Lyell Immunopharma, Telix Pharmaceuticals and others, are developing therapies for the Soft Tissue Sarcoma treatment
* Emerging Soft Tissue Sarcoma therapies such as AL3818, L19 TNF, Camsirubicin, and others are expected to have a significant impact on the Soft Tissue Sarcoma market in the coming years.
* In May 2024, Thermosome GmbH announced results of a Phase I Dose Escalation Study of 3-Weekly Intravenous DPPG2-TSL-DOX Combined With Regional Hyperthermia in Locally Advanced or Metastatic Soft Tissue Sarcoma
* In April 2024, Eli Lilly and Company has announced results of a Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin Plus Olaratumab Versus Doxorubicin Plus Placebo in Patients With Advanced or Metastatic Soft Tissue Sarcoma
* In April 2024, Philogen S.p.A. announced results of a Randomized Study to Investigate the Efficacy and Safety of the Tumor-targeting Human Antibody-cytokine Fusion Protein L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcoma
Soft Tissue Sarcoma Overview
Soft tissue sarcoma is a rare type of cancer that arises from the soft tissues of the body, such as muscles, fat, blood vessels, nerves, tendons, and the lining of joints. These cancers can develop anywhere in the body but are most commonly found in the arms, legs, and abdomen. There are more than 50 different subtypes of soft tissue sarcomas, each varying in aggressiveness and response to treatment.
The exact cause of soft tissue sarcomas is often unknown, but risk factors include genetic disorders (such as Li-Fraumeni syndrome and neurofibromatosis), exposure to certain chemicals (like herbicides and dioxins), and previous radiation therapy. Soft tissue sarcoma Symptoms typically present as a painless lump or swelling, but as the tumor grows, it can cause pain or interfere with normal bodily functions.
Soft tissue sarcoma Diagnosis involves imaging studies like MRI and CT scans, along with a biopsy to determine the type and grade of the tumor. Treatment options depend on the tumor's size, location, and stage, and often include surgery, radiation therapy, and chemotherapy. In some cases, targeted therapy or immunotherapy may be used, especially for metastatic or recurrent sarcomas.
Research is ongoing to develop more effective treatments and improve outcomes for patients with soft tissue sarcomas. Advances in molecular genetics and targeted therapies offer hope for more personalized and successful interventions in the future.
Get a Free Sample PDF Report to know more about Soft Tissue Sarcoma Pipeline Therapeutic Assessment- Soft Tissue Sarcoma Treatment Market [https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Soft Tissue Sarcoma Route of Administration
Soft Tissue Sarcoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
* Oral
* Parenteral
* Subcutaneous
* Topical
* Intravenous
Soft Tissue Sarcoma Molecule Type
Soft Tissue Sarcoma Products have been categorized under various Molecule types, such as
*
Monoclonal Antibody
*
Peptides
*
Polymer
*
Small molecule
*
Gene therapy
Soft Tissue Sarcoma Pipeline Therapeutics Assessment
* Soft Tissue Sarcoma Assessment by Product Type
* Soft Tissue Sarcoma By Stage and Product Type
* Soft Tissue Sarcoma Assessment by Route of Administration
* Soft Tissue Sarcoma By Stage and Route of Administration
* Soft Tissue Sarcoma Assessment by Molecule Type
* Soft Tissue Sarcoma by Stage and Molecule Type
DelveInsight's Soft Tissue Sarcoma Pipeline Report covers around 130+ products under different phases of clinical development like-
* Late-stage products (Phase III)
* Mid-stage products (Phase II)
* Early-stage product (Phase I)
* Pre-clinical and Discovery stage candidates
* Discontinued & Inactive candidates
* Route of Administration
Further Soft Tissue Sarcoma product details are provided in the report. Download the Soft Tissue Sarcoma pipeline report to learn more about the emerging Soft Tissue Sarcoma therapies- Soft Tissue Sarcoma Clinical Trials and FDA Approvals [https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Soft Tissue Sarcoma Pipeline Analysis:
The Soft Tissue Sarcoma pipeline report provides insights into
* The report provides detailed insights about companies that are developing therapies for the treatment of Soft Tissue Sarcoma with aggregate therapies developed by each company for the same.
* It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Soft Tissue Sarcoma Treatment.
* Soft Tissue Sarcoma key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
* Soft Tissue Sarcoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
* Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Soft Tissue Sarcoma market.
Download Sample PDF Report to know more about Soft Tissue Sarcoma drugs and therapies- Soft Tissue Sarcoma Therapeutic Assessment [https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Scope of Soft Tissue Sarcoma Pipeline Drug Insight
* Coverage: Global
* Key Soft Tissue Sarcoma Companies: Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm Therapeutics, Nanobiotix, Apexigen, Lytix Biopharma, Incyte Corporation, Iovance Biotherapeutics, Aadi Bioscience, Inc., AVEO Pharmaceuticals, Bayer, VasGene Therapeutics, Mirati Therapeutics, Novartis Pharmaceuticals, Incyte Corporation, Tracon Pharmaceuticals, Jiangsu Hengrui Medicine, Exelixis, Qbiotics, AstraZeneca, Loxo Oncology, ImmunityBio, Monopar Therapeutics, Chipscreen Biosciences, Ltd., Agenus, C4 Therapeutics, Inc., Noxopharm Limited, Moleculin Biotech, Inc., Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., Tracon Pharmaceuticals Inc., Guangdong Xiangxue Precision Medical Technology Co., Ltd., Cornerstone Pharmaceuticals, Takara Bio Inc., Jazz Pharmaceuticals, Lyell Immunopharma, Telix Pharmaceuticals and others.
* Key Soft Tissue Sarcoma Therapies: AL3818, L19 TNF, Camsirubicin, and others.
* Soft Tissue Sarcoma Therapeutic Assessment: Soft Tissue Sarcoma current marketed and Soft Tissue Sarcoma emerging therapies
* Soft Tissue Sarcoma Market Dynamics: Soft Tissue Sarcoma market drivers and Soft Tissue Sarcoma market barriers
Request for Sample PDF Report for Soft Tissue Sarcoma Pipeline Assessment and clinical trials - Soft Tissue Sarcoma Therapies and Drugs [https://www.delveinsight.com/sample-request/soft-tissue-sarcoma-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Table of Contents
1. Soft Tissue Sarcoma Report Introduction
2. Soft Tissue Sarcoma Executive Summary
3. Soft Tissue Sarcoma Overview
4. Soft Tissue Sarcoma- Analytical Perspective In-depth Commercial Assessment
5. Soft Tissue Sarcoma Pipeline Therapeutics
6. Soft Tissue Sarcoma Late Stage Products (Phase II/III)
7. Soft Tissue Sarcoma Mid Stage Products (Phase II)
8. Soft Tissue Sarcoma Early Stage Products (Phase I)
9. Soft Tissue Sarcoma Preclinical Stage Products
10. Soft Tissue Sarcoma Therapeutics Assessment
11. Soft Tissue Sarcoma Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Soft Tissue Sarcoma Companies
14. Soft Tissue Sarcoma Key Products
15. Soft Tissue Sarcoma Unmet Needs
16 . Soft Tissue Sarcoma Market Drivers and Barriers
17. Soft Tissue Sarcoma Future Perspectives and Conclusion
18. Soft Tissue Sarcoma Analyst Views
19. Appendix
20. About DelveInsight
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=soft-tissue-sarcoma-pipeline-analysis-2024-fda-approvals-clinical-trials-therapies-mechanism-of-action-route-of-administration-by-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432, Las Vegas NV 89107
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Soft Tissue Sarcoma Pipeline Analysis 2024: FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight here
News-ID: 3558386 • Views: …
More Releases from ABNewswire
What are the most effective medical therapies for managing excess body mass? Reg …
Cape Coral healthcare providers report breakthrough success using FDA-approved GLP-1 medications for weight management, with Premier Wellness Florida leading comprehensive treatment programs combining pharmaceuticals with holistic wellness support.
Cape Coral, FL - Recent clinical developments in medical weight management have prompted Southwest Florida healthcare providers to report significant patient success rates with FDA-approved medications and comprehensive treatment protocols. Premier Wellness Florida, operating from its Del Prado Boulevard facility, has documented patient…
Winkler Kurtz LLP - Long Island Lawyers Port Jefferson Station Injury Attorney O …
Winkler Kurtz LLP is a leading Long Island law firm specializing in personal injury cases such as car accidents, slip and falls, and medical malpractice. Offering decades of local experience, the firm provides compassionate support and skilled legal advocacy to help injury victims secure justice and compensation. With free consultations and a contingency fee policy, Winkler Kurtz LLP ensures quality legal help is available to all Long Islanders in need.
When…
How to Pick the Best Online Chemistry Tutoring Platform
Image: https://www.abnewswire.com/upload/2025/10/814f4b38d9855ce5fcc0509bfebaa240.jpg
Choosing the right chemistry tutoring platform can make the difference between academic success and continued struggles with complex reactions and molecular structures. With students increasingly turning to digital solutions for personalized learning support, the online chemistry tutoring market has exploded with options promising everything from AI-powered progress tracking to virtual lab experiences that transform how learners approach this challenging subject.
Essential Platform Features for Effective Online Chemistry Tutoring
Modern chemistry tutoring…
Chronic Myeloid Leukemia Pipeline Drugs Report 2025: Emerging Therapies, Clinica …
DelveInsight's "Chronic Myeloid Leukemia Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Chronic Myeloid Leukemia pipeline landscape. It covers the Chronic Myeloid Leukemia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Myeloid Leukemia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…
More Releases for Soft
Soft Drink Concentrates Market
Introduction
The soft drink concentrates market plays a pivotal role in the global beverage industry. These concentrates are primarily used to prepare soft drinks, offering a cost-effective and efficient way for manufacturers to produce various beverages. Soft drink concentrates are essentially flavored syrups or powders that, when mixed with water or carbonated water, create popular soft drinks. The market for these concentrates has seen remarkable growth in recent years, driven by…
Soft Robot Technology Market Upcoming Trend & Positions 2027 | Cyberdyne, Soft R …
Soft Robot Technology Market Strengths, Weaknesses, Opportunities, and Threats analysis.
Demanding Market Research Report on Global Soft Robot Technology Market conducted by a team of industry specialists. The report covers briefly the products or services in the market and their application. The report also provides data on the technological advancements taking place in the Soft Robot Technology market, helping the market vendors to increase their business productivity and operational efficiency. The…
Global Motor Soft Starter Market, Global Motor Soft Starter Industry, Market Rev …
The Motor soft starter has remarkable application in numerous end-use industries like oil & gas, mining and power generation trades. It supports in lessening the inflow current formed whereas motor start up and consequently boost the extending and proficiency of motor. Along with this, it knowingly assistances in governing motor acceleration which outcomes in safety of motor from much impairment while in complete procedure. It is an apparatus that is…
Soft Touch Film and Soft Touch Lamination Film Market Size, Share, Development b …
Global Info Research offers a latest published report on Soft Touch Film and Soft Touch Lamination Film Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Soft Touch Film and Soft Touch Lamination Film players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in…
Soft Skills Management Market - Increasing Demand For Cloud-Based Soft Skill Tra …
According to a new market report published by Transparency Market Research, the global soft skills management market was valued at US$ 11,289.7 Mn in 2016 and is expected to expand at a CAGR of 11.9% from 2018 to 2026, reaching US$ 33,736.1 Mn by the end of the forecast period. According to the report, the global soft skills management market will continue to be influenced by a range of macroeconomic…
Suma Soft
Texas (USA), Canada (Toronto) & India (Business Network)— Suma Soft’s BPO for companies in USA, Canada and UK efficiently streamline business processes. Suma Soft has developed an integrated back-office system that assists these companies giving them round the clock support.
Credibility & Certification :
Suma Soft is an ISO 27001 and 9001 certified company which gives paramount importance to security, accuracy and quality while delivering BPO support services. We have a…
